日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Mycoplasma gallisepticum 30S ribosomal protein S13 (rpsM) CSB-YP886470MWI
CSB-EP886470MWI
CSB-BP886470MWI
CSB-MP886470MWI
CSB-EP886470MWI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant HPr kinase/phosphorylase (hprK) CSB-YP886471LMH
CSB-EP886471LMH
CSB-BP886471LMH
CSB-MP886471LMH
CSB-EP886471LMH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodobacter sphaeroides Hydrogenase nickel incorporation protein HypA (hypA) CSB-YP886472RLE
CSB-EP886472RLE
CSB-BP886472RLE
CSB-MP886472RLE
CSB-EP886472RLE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Zymomonas mobilis Ribosomal RNA small subunit methyltransferase H (rsmH) CSB-YP886473ZBM
CSB-EP886473ZBM
CSB-BP886473ZBM
CSB-MP886473ZBM
CSB-EP886473ZBM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phospholipase C (plc) CSB-YP886474CMB
CSB-EP886474CMB
CSB-BP886474CMB
CSB-MP886474CMB
CSB-EP886474CMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xylose isomerase (xylA) CSB-YP886475FOI
CSB-EP886475FOI
CSB-BP886475FOI
CSB-MP886475FOI
CSB-EP886475FOI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio harveyi Na (+)-translocating NADH-quinone reductase subunit C (nqrC), partial CSB-YP886476VEA1
CSB-EP886476VEA1
CSB-BP886476VEA1
CSB-MP886476VEA1
CSB-EP886476VEA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Capsular polysaccharide phosphotransferase lcbA (lcbA) CSB-YP886477NBJ
CSB-EP886477NBJ
CSB-BP886477NBJ
CSB-MP886477NBJ
CSB-EP886477NBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Listeria monocytogenes serovar 1/2a Regulatory protein spx (spxA) CSB-YP886478LPY
CSB-EP886478LPY
CSB-BP886478LPY
CSB-MP886478LPY
CSB-EP886478LPY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus pseudofirmus Na (+)/H (+) antiporter subunit F (mrpF), partial CSB-YP886479BRB1
CSB-EP886479BRB1
CSB-BP886479BRB1
CSB-MP886479BRB1
CSB-EP886479BRB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Zymomonas mobilis ATP phosphoribosyltransferase (hisG) CSB-YP886480ZBM
CSB-EP886480ZBM
CSB-BP886480ZBM
CSB-MP886480ZBM
CSB-EP886480ZBM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bradyrhizobium japonicum DNA repair protein recO (recO) CSB-YP886481BVW
CSB-EP886481BVW
CSB-BP886481BVW
CSB-MP886481BVW
CSB-EP886481BVW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Single-stranded DNA-binding protein 2 (ssb2) CSB-YP886482SWW
CSB-EP886482SWW
CSB-BP886482SWW
CSB-MP886482SWW
CSB-EP886482SWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Comamonas testosteroni Acetaldehyde dehydrogenase 2 (aphF) CSB-YP886483CNN
CSB-EP886483CNN
CSB-BP886483CNN
CSB-MP886483CNN
CSB-EP886483CNN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium ammoniagenes Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC) CSB-YP886484DWW
CSB-EP886484DWW
CSB-BP886484DWW
CSB-MP886484DWW
CSB-EP886484DWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Low calcium response locus protein T (lcrT) CSB-YP886485YAS
CSB-EP886485YAS
CSB-BP886485YAS
CSB-MP886485YAS
CSB-EP886485YAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptomyces coelicolor Proteasome-associated ATPase (arc), partial CSB-YP886486FOB
CSB-EP886486FOB
CSB-BP886486FOB
CSB-MP886486FOB
CSB-EP886486FOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptomyces coelicolor Uncharacterized protein SCO0757 (SCO0757) CSB-YP886487FOB
CSB-EP886487FOB
CSB-BP886487FOB
CSB-MP886487FOB
CSB-EP886487FOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptomyces coelicolor Xylulose kinase (xylB) CSB-YP886488FOB
CSB-EP886488FOB
CSB-BP886488FOB
CSB-MP886488FOB
CSB-EP886488FOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptomyces coelicolor Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC) CSB-YP886489FOB
CSB-EP886489FOB
CSB-BP886489FOB
CSB-MP886489FOB
CSB-EP886489FOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×